CLINICAL_TRIALS
trial_result
· 2011-07-01
Clinical Trial Update: Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007) [Phase 3]
Summary
This entry notes the completion of a Phase 3 trial (ST-603-007) evaluating cyclosporine for dry eye syndrome, sponsored by Sirion Therapeutics.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sirion Therapeutics, Inc. | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED